Taking the Sting out of Pain Management: Strategies for Assessment and Treatment
Live, virtual training through WebExJoin to learn about screening, diagnosing, and treating OUD, including harm reduction tools.
Hosted by: Maryland Addiction Consultation Service (MACS)
Audience: Primary Care Physicians, Advance Practice Registered Nurses, Physician Assistants, other members of the healthcare team
Learning Objectives: 1. Describe the comprehensive assessment process for patients experiencing acute, subacute, or chronic pain.
2. Outline key components of developing an effective pain management treatment plan.
3. Recognize the importance of multidisciplinary approach in managing pain.
Presenter: Sarah Merritt, MD Consultant, Maryland Addiction Consultation Service (MACS)
Board-Certified Pain Management Specialist, Lifestream Health Center
Disclosure Information:
The planners and reviewers for this activity have reported no relevant financial relationships to disclose.
Event contact: Bridget Sweeney, MACS Training Coordinator MACSTraining@som.umaryland.edu
CME Credit:
Accreditation Statement:
"This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of MedChi, The Maryland State Medical Society and the Maryland Addiction Consultation Service (MACS). MedChi is accredited by the ACCME to provide continuing medical education for physicians."
Designation Statement: "MedChi designates this live activity for a maximum of
1 AMA PRA Category 1TM Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity."
CEU Credit:
Maryland Addiction Consultation Service (MACS) of the University of Maryland School of Medicine, Department of Psychiatry is authorized as a sponsor of Continuing Education Units. MACS maintains responsibility for this program.
MAT and MATE Acts:
This training counts toward the 8-hour training requirement of the 2023 MATE Act. On December 29, 2022, President Biden signed the fiscal year 2023 omnibus, passing the Mainstreaming Addiction Treatment (MAT) and Medication Access and Training Expansion (MATE) Acts. These bills were passed to expand access to buprenorphine for the treatment of opioid use disorder, and normalize and enhance substance use care across healthcare settings.
MACS is monitoring guidance from state and federal agencies closely and will update this page when more information becomes available. The resources on this page offer information about the omnibus, the bills, and the implications for healthcare providers and programs. Find out more here: https://www.marylandmacs.org/mat--mate-acts/https://www.marylandmacs.org/MAT--MATE-Acts/